When the building was completed, in addition to being able to produce MK in their own controlled facility, announcements and articles were written about the potential for other pharma and biotech companies contracting with CVM for shifts to produce biologics, stem cells etc. I believe they estimated potentially something like $20,000 per shift per day of additional revenue. Could be off on the amounts they estimated. I'm sure Garza & Vinnie wrote about it. Since Vinnie reads this board like the bible maybe he'll chime in wih reference links. So yeah, you're right, good memory. Only one prob. No one is interested. Unless it's still going to happen. But it's interesting that no one speaks of it anymore.
I am not a Bashturd; however, I am not immune d of being being brain dead either; guess why, cause I am also a human.
Back to your Question:
CVM's facility is currently set up to produce Multikine, and plenty of it (I might add) is needed for the P3 trial. It is simply not worth risking rent to any given company and have the facility produce more than one product, and who says that the company renting the space w'ont turn out to be hired by a hedge fund or the likes, to try to mess up the Multikine production process, and also may be steal the formula of how Multkine is produced. It is simply not worth the risk or the money made from the rent.
CVM has so much riding on Multikine, that being secretive about anything that has to do Multikine is the way to go. I applaud CVM management for that.
Hey...cho cha...your not busy either, I got customers to feed..now get back to rolling those taco's or I'm gonna put you at the Blue Fox handing out napkins for your little seeeester and your stinking old madre......